LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Barasertib | 1.11 | uM | LJP5 | 3 | D09 | 72 | hr | 658 | 1229 | 3938 | 0.3121 | 0.2737 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 1 | D08 | 72 | hr | 658 | 1156 | 3908 | 0.2958 | 0.2450 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 2 | D08 | 72 | hr | 658 | 1175 | 3953 | 0.2972 | 0.2511 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 3 | D08 | 72 | hr | 658 | 1134 | 3938 | 0.2879 | 0.2346 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 1 | D07 | 72 | hr | 658 | 955 | 3908 | 0.2443 | 0.1558 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 2 | D07 | 72 | hr | 658 | 928 | 3953 | 0.2347 | 0.1420 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 3 | D07 | 72 | hr | 658 | 932 | 3938 | 0.2366 | 0.1443 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 1 | C18 | 72 | hr | 658 | 4107 | 3908 | 1.0508 | 1.0389 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 2 | C18 | 72 | hr | 658 | 4001 | 3953 | 1.0120 | 1.0092 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 3 | C18 | 72 | hr | 658 | 4133 | 3938 | 1.0494 | 1.0377 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 1 | C17 | 72 | hr | 658 | 3954 | 3908 | 1.0116 | 1.0090 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 2 | C17 | 72 | hr | 658 | 4016 | 3953 | 1.0158 | 1.0121 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 3 | C17 | 72 | hr | 658 | 4124 | 3938 | 1.0471 | 1.0360 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 1 | C16 | 72 | hr | 658 | 3786 | 3908 | 0.9687 | 0.9754 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 2 | C16 | 72 | hr | 658 | 3848 | 3953 | 0.9733 | 0.9792 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 3 | C16 | 72 | hr | 658 | 4043 | 3938 | 1.0266 | 1.0204 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 1 | C15 | 72 | hr | 658 | 3703 | 3908 | 0.9474 | 0.9584 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 2 | C15 | 72 | hr | 658 | 3644 | 3953 | 0.9217 | 0.9379 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 3 | C15 | 72 | hr | 658 | 3779 | 3938 | 0.9595 | 0.9682 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 1 | C14 | 72 | hr | 658 | 2949 | 3908 | 0.7545 | 0.7924 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 2 | C14 | 72 | hr | 658 | 3138 | 3953 | 0.7937 | 0.8291 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 3 | C14 | 72 | hr | 658 | 3034 | 3938 | 0.7704 | 0.8077 |
Hs 578T | Vemurafenib | 10 | uM | LJP5 | 1 | C13 | 72 | hr | 658 | 1963 | 3908 | 0.5022 | 0.5299 |
Hs 578T | Vemurafenib | 10 | uM | LJP5 | 2 | C13 | 72 | hr | 658 | 1962 | 3953 | 0.4962 | 0.5254 |
Hs 578T | Vemurafenib | 10 | uM | LJP5 | 3 | C13 | 72 | hr | 658 | 1822 | 3938 | 0.4626 | 0.4836 |